APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pathology Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pathology Testing Services Market Outlook and Growth Opportunities 2026

Report ID 17421060041 January 2026205 pages

Choose your research edition.

Industry ResearchPathology Testing Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathology Testing Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pathology Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathology Testing Services Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathology Testing Services Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Pathology Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pathology Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pathology Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pathology Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pathology Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pathology Testing Services market include Quest Diagnostics, BML, Dianon, Pathology Laboratories, Experimental Pathology Laboratories,Inc., PathAI, Randox Health, ACE Laboratory Services and Clinical Labs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pathology Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pathology Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pathology Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pathology Testing Services market.

Pathology Testing Services Segment by Company

Quest Diagnostics

BML

Dianon

Pathology Laboratories

Experimental Pathology Laboratories,Inc.

PathAI

Randox Health

ACE Laboratory Services

Clinical Labs

SYNLAB UK & Ireland

Metropolis Healthcare Ltd.

Acupath Laboratories

Clinipath (Malaysia) Sdn Bhd

QML Pathology Vetnostics

Confluence Health

MPS Ltd

Quest Diagnostics Newsroom

Targos

Sonic Healthcare Limited

Pathology Testing Services Segment by Type

Histopathological Examination

Cytopathological Examination

Molecular Pathology Examination

Pathology Testing Services Segment by Application

Hospital

Clinic

Research Institutions

Pathology Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pathology Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pathology Testing Services key companies, revenue, market share, and recent developments.

3. To split the Pathology Testing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pathology Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pathology Testing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Pathology Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathology Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pathology Testing Services industry.

Chapter 3: Detailed analysis of Pathology Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pathology Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pathology Testing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pathology Testing Services Industry Trends Table 2. Pathology Testing Services Industry Drivers Table 3. Pathology Testing Services Industry Opportunities and Challenges Table 4. Pathology Testing Services Industry Restraints Table 5. Global Pathology Testing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pathology Testing Services Revenue Share by Company (2021-2026) Table 7. Global Pathology Testing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pathology Testing Services Key Company Manufacturing Base & Headquarters Table 9. Global Pathology Testing Services Company, Product Type & Application Table 10. Global Pathology Testing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pathology Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Histopathological Examination Table 15. Significant Companies of Cytopathological Examination Table 16. Significant Companies of Molecular Pathology Examination Table 17. Global Pathology Testing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pathology Testing Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Pathology Testing Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Pathology Testing Services Sales Value Share by Type (2021-2026) Table 21. Global Pathology Testing Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Clinic Table 24. Significant Companies of Research Institutions Table 25. Global Pathology Testing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pathology Testing Services Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pathology Testing Services Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pathology Testing Services Sales Value Share by Application (2021-2026) Table 29. Global Pathology Testing Services Sales Value Share by Application (2027-2032) Table 30. Global Pathology Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pathology Testing Services Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pathology Testing Services Sales Value Share by Region (2021-2026) Table 33. Global Pathology Testing Services Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pathology Testing Services Sales Value Share by Region (2027-2032) Table 35. Global Pathology Testing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pathology Testing Services Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pathology Testing Services Sales Value Market Share by Country (2021-2026) Table 38. Global Pathology Testing Services Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pathology Testing Services Sales Value Market Share by Country (2027-2032) Table 40. Quest Diagnostics Company Information Table 41. Quest Diagnostics Business Overview Table 42. Quest Diagnostics Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Quest Diagnostics Pathology Testing Services Product Portfolio Table 44. Quest Diagnostics Recent Development Table 45. BML Company Information Table 46. BML Business Overview Table 47. BML Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. BML Pathology Testing Services Product Portfolio Table 49. BML Recent Development Table 50. Dianon Company Information Table 51. Dianon Business Overview Table 52. Dianon Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Dianon Pathology Testing Services Product Portfolio Table 54. Dianon Recent Development Table 55. Pathology Laboratories Company Information Table 56. Pathology Laboratories Business Overview Table 57. Pathology Laboratories Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Pathology Laboratories Pathology Testing Services Product Portfolio Table 59. Pathology Laboratories Recent Development Table 60. Experimental Pathology Laboratories,Inc. Company Information Table 61. Experimental Pathology Laboratories,Inc. Business Overview Table 62. Experimental Pathology Laboratories,Inc. Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Experimental Pathology Laboratories,Inc. Pathology Testing Services Product Portfolio Table 64. Experimental Pathology Laboratories,Inc. Recent Development Table 65. PathAI Company Information Table 66. PathAI Business Overview Table 67. PathAI Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. PathAI Pathology Testing Services Product Portfolio Table 69. PathAI Recent Development Table 70. Randox Health Company Information Table 71. Randox Health Business Overview Table 72. Randox Health Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Randox Health Pathology Testing Services Product Portfolio Table 74. Randox Health Recent Development Table 75. ACE Laboratory Services Company Information Table 76. ACE Laboratory Services Business Overview Table 77. ACE Laboratory Services Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. ACE Laboratory Services Pathology Testing Services Product Portfolio Table 79. ACE Laboratory Services Recent Development Table 80. Clinical Labs Company Information Table 81. Clinical Labs Business Overview Table 82. Clinical Labs Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Clinical Labs Pathology Testing Services Product Portfolio Table 84. Clinical Labs Recent Development Table 85. SYNLAB UK & Ireland Company Information Table 86. SYNLAB UK & Ireland Business Overview Table 87. SYNLAB UK & Ireland Pathology Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. SYNLAB UK & Ireland Pathology Testing Services Product Portfolio Table 89. SYNLAB UK & Ireland Recent Development Table 90. Metropolis Healthcare Ltd. Company Information Table 91. Metropolis Healthcare Ltd. Business Overview Table 92. Metropolis Healthcare Ltd. Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Metropolis Healthcare Ltd. Pathology Testing Services Product Portfolio Table 94. Metropolis Healthcare Ltd. Recent Development Table 95. Acupath Laboratories Company Information Table 96. Acupath Laboratories Business Overview Table 97. Acupath Laboratories Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Acupath Laboratories Pathology Testing Services Product Portfolio Table 99. Acupath Laboratories Recent Development Table 100. Clinipath (Malaysia) Sdn Bhd Company Information Table 101. Clinipath (Malaysia) Sdn Bhd Business Overview Table 102. Clinipath (Malaysia) Sdn Bhd Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Clinipath (Malaysia) Sdn Bhd Pathology Testing Services Product Portfolio Table 104. Clinipath (Malaysia) Sdn Bhd Recent Development Table 105. QML Pathology Vetnostics Company Information Table 106. QML Pathology Vetnostics Business Overview Table 107. QML Pathology Vetnostics Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. QML Pathology Vetnostics Pathology Testing Services Product Portfolio Table 109. QML Pathology Vetnostics Recent Development Table 110. Confluence Health Company Information Table 111. Confluence Health Business Overview Table 112. Confluence Health Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Confluence Health Pathology Testing Services Product Portfolio Table 114. Confluence Health Recent Development Table 115. MPS Ltd Company Information Table 116. MPS Ltd Business Overview Table 117. MPS Ltd Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. MPS Ltd Pathology Testing Services Product Portfolio Table 119. MPS Ltd Recent Development Table 120. Quest Diagnostics Newsroom Company Information Table 121. Quest Diagnostics Newsroom Business Overview Table 122. Quest Diagnostics Newsroom Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Quest Diagnostics Newsroom Pathology Testing Services Product Portfolio Table 124. Quest Diagnostics Newsroom Recent Development Table 125. Targos Company Information Table 126. Targos Business Overview Table 127. Targos Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Targos Pathology Testing Services Product Portfolio Table 129. Targos Recent Development Table 130. Sonic Healthcare Limited Company Information Table 131. Sonic Healthcare Limited Business Overview Table 132. Sonic Healthcare Limited Pathology Testing Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Sonic Healthcare Limited Pathology Testing Services Product Portfolio Table 134. Sonic Healthcare Limited Recent Development Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Pathology Testing Services Product Image Figure 2. Global Pathology Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathology Testing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Pathology Testing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Histopathological Examination Image Figure 8. Cytopathological Examination Image Figure 9. Molecular Pathology Examination Image Figure 10. Global Pathology Testing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pathology Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Pathology Testing Services Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Research Institutions Image Figure 16. Global Pathology Testing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pathology Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pathology Testing Services Sales Value Share by Application (2021-2032) Figure 19. Global Pathology Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pathology Testing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pathology Testing Services Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pathology Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pathology Testing Services Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pathology Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pathology Testing Services Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pathology Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pathology Testing Services Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pathology Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pathology Testing Services Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pathology Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pathology Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pathology Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pathology Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Histopathological Examination
  • Cytopathological Examination
  • Molecular Pathology Examination
Applications
  • Hospital
  • Clinic
  • Research Institutions
Companies covered
  • Quest Diagnostics
  • BML
  • Dianon
  • Pathology Laboratories
  • Experimental Pathology Laboratories,Inc.
  • PathAI
  • Randox Health
  • ACE Laboratory Services
  • Clinical Labs
  • SYNLAB UK & Ireland
  • Metropolis Healthcare Ltd.
  • Acupath Laboratories
  • Clinipath (Malaysia) Sdn Bhd
  • QML Pathology Vetnostics
  • Confluence Health
  • MPS Ltd
  • Quest Diagnostics Newsroom
  • Targos
  • Sonic Healthcare Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pathology Testing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pathology Testing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pathology Testing Services Market Dynamics
  1. 2.1 Pathology Testing Services Industry Trends
  2. 2.2 Pathology Testing Services Industry Drivers
  3. 2.3 Pathology Testing Services Industry Opportunities and Challenges
  4. 2.4 Pathology Testing Services Industry Restraints
3 Pathology Testing Services Market by Company
  1. 3.1 Global Pathology Testing Services Company Revenue Ranking in 2025
  2. 3.2 Global Pathology Testing Services Revenue by Company (2021-2026)
  3. 3.3 Global Pathology Testing Services Company Ranking (2024-2026)
  4. 3.4 Global Pathology Testing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Pathology Testing Services Company Product Type and Application
  6. 3.6 Global Pathology Testing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pathology Testing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pathology Testing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pathology Testing Services Market by Type
  1. 4.1 Pathology Testing Services Type Introduction
  2. 4.1.1 Histopathological Examination
  3. 4.1.2 Cytopathological Examination
  4. 4.1.3 Molecular Pathology Examination
  5. 4.2 Global Pathology Testing Services Sales Value by Type
  6. 4.2.1 Global Pathology Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pathology Testing Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Pathology Testing Services Sales Value Share by Type (2021-2032)
5 Pathology Testing Services Market by Application
  1. 5.1 Pathology Testing Services Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Research Institutions
  5. 5.2 Global Pathology Testing Services Sales Value by Application
  6. 5.2.1 Global Pathology Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pathology Testing Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pathology Testing Services Sales Value Share by Application (2021-2032)
6 Pathology Testing Services Regional Value Analysis
  1. 6.1 Global Pathology Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pathology Testing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pathology Testing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pathology Testing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pathology Testing Services Sales Value (2021-2032)
  7. 6.3.2 North America Pathology Testing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pathology Testing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Pathology Testing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pathology Testing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pathology Testing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pathology Testing Services Sales Value (2021-2032)
  16. 6.6.2 South America Pathology Testing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pathology Testing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pathology Testing Services Sales Value Share by Country, 2025 VS 2032
7 Pathology Testing Services Country-level Value Analysis
  1. 7.1 Global Pathology Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pathology Testing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pathology Testing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pathology Testing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pathology Testing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pathology Testing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pathology Testing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pathology Testing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pathology Testing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pathology Testing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pathology Testing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pathology Testing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pathology Testing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pathology Testing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pathology Testing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pathology Testing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pathology Testing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pathology Testing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pathology Testing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pathology Testing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pathology Testing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pathology Testing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pathology Testing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pathology Testing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pathology Testing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pathology Testing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pathology Testing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pathology Testing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pathology Testing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pathology Testing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pathology Testing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pathology Testing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pathology Testing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pathology Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quest Diagnostics
  2. 8.1.1 Quest Diagnostics Company Information
  3. 8.1.2 Quest Diagnostics Business Overview
  4. 8.1.3 Quest Diagnostics Pathology Testing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quest Diagnostics Pathology Testing Services Product Portfolio
  6. 8.1.5 Quest Diagnostics Recent Developments
  7. 8.2 BML
  8. 8.2.1 BML Company Information
  9. 8.2.2 BML Business Overview
  10. 8.2.3 BML Pathology Testing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BML Pathology Testing Services Product Portfolio
  12. 8.2.5 BML Recent Developments
  13. 8.3 Dianon
  14. 8.3.1 Dianon Company Information
  15. 8.3.2 Dianon Business Overview
  16. 8.3.3 Dianon Pathology Testing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dianon Pathology Testing Services Product Portfolio
  18. 8.3.5 Dianon Recent Developments
  19. 8.4 Pathology Laboratories
  20. 8.4.1 Pathology Laboratories Company Information
  21. 8.4.2 Pathology Laboratories Business Overview
  22. 8.4.3 Pathology Laboratories Pathology Testing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pathology Laboratories Pathology Testing Services Product Portfolio
  24. 8.4.5 Pathology Laboratories Recent Developments
  25. 8.5 Experimental Pathology Laboratories,Inc.
  26. 8.5.1 Experimental Pathology Laboratories,Inc. Company Information
  27. 8.5.2 Experimental Pathology Laboratories,Inc. Business Overview
  28. 8.5.3 Experimental Pathology Laboratories,Inc. Pathology Testing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Experimental Pathology Laboratories,Inc. Pathology Testing Services Product Portfolio
  30. 8.5.5 Experimental Pathology Laboratories,Inc. Recent Developments
  31. 8.6 PathAI
  32. 8.6.1 PathAI Company Information
  33. 8.6.2 PathAI Business Overview
  34. 8.6.3 PathAI Pathology Testing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PathAI Pathology Testing Services Product Portfolio
  36. 8.6.5 PathAI Recent Developments
  37. 8.7 Randox Health
  38. 8.7.1 Randox Health Company Information
  39. 8.7.2 Randox Health Business Overview
  40. 8.7.3 Randox Health Pathology Testing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Randox Health Pathology Testing Services Product Portfolio
  42. 8.7.5 Randox Health Recent Developments
  43. 8.8 ACE Laboratory Services
  44. 8.8.1 ACE Laboratory Services Company Information
  45. 8.8.2 ACE Laboratory Services Business Overview
  46. 8.8.3 ACE Laboratory Services Pathology Testing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ACE Laboratory Services Pathology Testing Services Product Portfolio
  48. 8.8.5 ACE Laboratory Services Recent Developments
  49. 8.9 Clinical Labs
  50. 8.9.1 Clinical Labs Company Information
  51. 8.9.2 Clinical Labs Business Overview
  52. 8.9.3 Clinical Labs Pathology Testing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Clinical Labs Pathology Testing Services Product Portfolio
  54. 8.9.5 Clinical Labs Recent Developments
  55. 8.10 SYNLAB UK & Ireland
  56. 8.10.1 SYNLAB UK & Ireland Company Information
  57. 8.10.2 SYNLAB UK & Ireland Business Overview
  58. 8.10.3 SYNLAB UK & Ireland Pathology Testing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SYNLAB UK & Ireland Pathology Testing Services Product Portfolio
  60. 8.10.5 SYNLAB UK & Ireland Recent Developments
  61. 8.11 Metropolis Healthcare Ltd.
  62. 8.11.1 Metropolis Healthcare Ltd. Company Information
  63. 8.11.2 Metropolis Healthcare Ltd. Business Overview
  64. 8.11.3 Metropolis Healthcare Ltd. Pathology Testing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Metropolis Healthcare Ltd. Pathology Testing Services Product Portfolio
  66. 8.11.5 Metropolis Healthcare Ltd. Recent Developments
  67. 8.12 Acupath Laboratories
  68. 8.12.1 Acupath Laboratories Company Information
  69. 8.12.2 Acupath Laboratories Business Overview
  70. 8.12.3 Acupath Laboratories Pathology Testing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Acupath Laboratories Pathology Testing Services Product Portfolio
  72. 8.12.5 Acupath Laboratories Recent Developments
  73. 8.13 Clinipath (Malaysia) Sdn Bhd
  74. 8.13.1 Clinipath (Malaysia) Sdn Bhd Company Information
  75. 8.13.2 Clinipath (Malaysia) Sdn Bhd Business Overview
  76. 8.13.3 Clinipath (Malaysia) Sdn Bhd Pathology Testing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Clinipath (Malaysia) Sdn Bhd Pathology Testing Services Product Portfolio
  78. 8.13.5 Clinipath (Malaysia) Sdn Bhd Recent Developments
  79. 8.14 QML Pathology Vetnostics
  80. 8.14.1 QML Pathology Vetnostics Company Information
  81. 8.14.2 QML Pathology Vetnostics Business Overview
  82. 8.14.3 QML Pathology Vetnostics Pathology Testing Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 QML Pathology Vetnostics Pathology Testing Services Product Portfolio
  84. 8.14.5 QML Pathology Vetnostics Recent Developments
  85. 8.15 Confluence Health
  86. 8.15.1 Confluence Health Company Information
  87. 8.15.2 Confluence Health Business Overview
  88. 8.15.3 Confluence Health Pathology Testing Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Confluence Health Pathology Testing Services Product Portfolio
  90. 8.15.5 Confluence Health Recent Developments
  91. 8.16 MPS Ltd
  92. 8.16.1 MPS Ltd Company Information
  93. 8.16.2 MPS Ltd Business Overview
  94. 8.16.3 MPS Ltd Pathology Testing Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 MPS Ltd Pathology Testing Services Product Portfolio
  96. 8.16.5 MPS Ltd Recent Developments
  97. 8.17 Quest Diagnostics Newsroom
  98. 8.17.1 Quest Diagnostics Newsroom Company Information
  99. 8.17.2 Quest Diagnostics Newsroom Business Overview
  100. 8.17.3 Quest Diagnostics Newsroom Pathology Testing Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Quest Diagnostics Newsroom Pathology Testing Services Product Portfolio
  102. 8.17.5 Quest Diagnostics Newsroom Recent Developments
  103. 8.18 Targos
  104. 8.18.1 Targos Company Information
  105. 8.18.2 Targos Business Overview
  106. 8.18.3 Targos Pathology Testing Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Targos Pathology Testing Services Product Portfolio
  108. 8.18.5 Targos Recent Developments
  109. 8.19 Sonic Healthcare Limited
  110. 8.19.1 Sonic Healthcare Limited Company Information
  111. 8.19.2 Sonic Healthcare Limited Business Overview
  112. 8.19.3 Sonic Healthcare Limited Pathology Testing Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Sonic Healthcare Limited Pathology Testing Services Product Portfolio
  114. 8.19.5 Sonic Healthcare Limited Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst